<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: Nasal natural killer (NK)/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> is characterized by chemo-resistance, angiodestruction, and aggressive <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Few studies exist on molecular characteristics of this disease entity </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Expression levels of major <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-related proteins Bcl-2, Bcl-x, Mcl-1, Bax, and a proliferative marker Ki-67 were analyzed in 11 nasal NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cases by immunohistochemical methods </plain></SENT>
<SENT sid="3" pm="."><plain>Nine cases were of NK-cell lineage and two cases were of T-cell lineage </plain></SENT>
<SENT sid="4" pm="."><plain>For comparison, 12 follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (FL) cases and 16 diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e>) cases were also studied </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS AND CONCLUSIONS: Bax expression was low in <z:hpo ids='HP_0000001'>all</z:hpo> nasal NK-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cases, which constitute the major population of nasal NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Bax expression in nasal NK-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> was similar to FL and significantly lower compared with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Bcl-2 expression was significantly lower in nasal NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> compared with that of FL and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DLBCL</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Bcl-x expression was high in <z:hpo ids='HP_0000001'>all</z:hpo> three <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>Two distinct Mcl-1 expression groups existed for nasal NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (6.2 +/- 5.2% and 59.1 +/- 12.3%, 95% CI) </plain></SENT>
<SENT sid="10" pm="."><plain>Ki-67 expression was high in nasal NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and worse prognostic groups tended to express higher levels of Ki-67 </plain></SENT>
<SENT sid="11" pm="."><plain>The results suggest a combination of impaired <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and aggressive proliferation in nasal NK/T-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and may provide explanations for its poor prognosis </plain></SENT>
</text></document>